ALung Technologies filed an SEC Form D to confirm the sale of $2 million in debt, options, warrants and other rights to purchase securities. The Pittsburgh-based company made its first sale in the new notice on May 20 and reached its offering total of $2 million by June 1. Just one investor participated in the […]
ALung Technologies Inc.
FDA grants ALung EUA for respiratory assist system
ALung Technologies announced today that it received FDA emergency use authorization (EUA) for its Hemolung respiratory assist system (RAS) for treating COVID-19. Pittsburgh-based ALung said in a news release that it already treated numerous COVID-19 patients in the U.S. under existing FDA emergency use provisions, as well as in Europe, where it’s had CE Mark […]
Safety board OK’s continuing trial of ALung’s Hemolung RAS device
ALung Technologies said yesterday that it won approval from an independent Data and Safety Monitoring board to continue the U.S.-based VENT-AVOID clinical trial of its low-flow extracorporeal carbon dioxide removal technology intended to treat COPD patients with acute respiratory failure. The Pittsburgh-based company said that the VENT-AVOID trial looks to validate the safety and efficacy […]
Bone adhesive dev Launchpad Medical raises $9m | Medtech Funding Roundup
Launchpad Medical has raised $8.5 million in a new round of equity financing, according to recently posted SEC filings. The Lowell, Mass.-based medtech company is developing the Tetranite injectable, synthetic adhesive solution intended for bone repair. Tetranite is bioresorbable and is designed to provide instant adhesive capabilities to treat fractured bone and to stabilize metal […]
ALung submits FDA IDE app for HemoLung device
ALung Technologies said today it submitted an investigational device exemption application to the FDA as it seeks to begin a clinical study of its Hemolung Respiratory Assist System. The Pittsburgh, Penn.-based company is developing the Hemolung device, an extracorporeal carbon dioxide removal system that works by removing carbon dioxide and delivering oxygen directly to a patient’s blood […]
ALung closes $36m Series C
Artificial lung-like device developer ALung Technologies said today it closed a $36 million Series C financing round, with funds slated to support a US pivotal trial of its Hemolung respiratory assist system as it pursues FDA approval. The Pittsburgh, Penn.-based company is developing the Hemolung device, an extracorporeal carbon dioxide removal system that works by removing carbon […]
ALung raises $2.6m
Artificial lung-like device developer ALung Technologies raised $2.6 million in a new round of debt and options financing, according to an SEC filing posted this week. The Pittsburgh, Penn.-based company is developing the Hemolung device, an extracorporeal carbon dioxide removal system that works by removing carbon dioxide and delivering oxygen directly to a patient’s blood via […]
ALung Technologies brings in $2.6m
Artificial lung-like device developer ALung Technologies has raised $2.6 million in a new round of financing, according to an SEC filing posted this week. Pittsburgh-based ALung’s Hemolung device is an extracorporeal carbon dioxide removal system that works by removing carbon dioxide and delivering oxygen directly to a patient’s blood via a small catheter inserted […]
Artificial lung developer ALung raises $12m
Artificial lung-like device developer ALung Technologies said today it closed a $12 million round of financing to support the continued commercialization of its minimally invasive Hemolung Respiratory Assist System. Pittsburgh-based ALung’s Hemolung device is an extracorporeal carbon dioxide removal system that works by removing carbon dioxide and delivering oxygen directly to a patient’s blood via a small […]
ALung’s artificial lung tech selected for landmark pivotal trial
ALung Technologies said today its Hemolung RAS extracorporeal carbon dioxide removal device has been selected for use in the world’s 1st pivotal trial of ECCO2R technology used to treat patients with acute respiratory failure. The U.K.’s National Institute for Health Research will supply $3.1 million (GBP £2.1 million) in funding for the 1,120 patient Rest […]
